← Leaderboards
Paul D. Robbins
Mayo Clinic Rochester
$18,718,334
Attributed
$18,718,334
Total exposure
22
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$44,914,772 · 26
By mechanism
P01$17,874,705 · 6
U19$10,673,360 · 3
U54$9,401,612 · 3
P30$3,317,331 · 6
R01$2,401,482 · 2
N01$503,185 · 1
Top collaborators
- Nir J Barzilai3 shared
- Gr Scott Budinger3 shared
- Sundeep Khosla3 shared
- Jan No Middle Name Vijg3 shared
- Laura Jane Niedernhofer1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Nathan K Lebrasseur$21,937,905
- Sundeep Khosla$91,221,003
- Robert John Pignolo$5,555,703
- Latonya J Hickson$2,371,961
- Joao Passos$7,873,363
Others in their field
Top investigators on “Aging”
- Lawrence Corey · Fred Hutchinson Cancer Center$506,603,345
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,438,389
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$281,021,854
- George R Seage · Abt Associates, Inc.$218,167,298
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$210,610,900
Research focus
AgingCellsTissuesSenescenceIn VivoCell AgingMouse ModelIn VitroPhenotypeAgedPathway InteractionsLeadAge RelatedPlayUniversitiesProteinsCell TypeStem CellsAutomobile DrivingLongevityApoptosisGeneticProgramsSignal Transduction
Grant awards (77)
Midwest Murine-Tissue Mapping Center (MM-TMC)$2,700,000
U54 · FY2025 · AG · contact PI
Genetic variant-based drug discovery targeting conserved pathways of aging$2,640,750
U19 · FY2025 · AG
Minnesota Nathan Shock Center of Excellence on Genome Integrity and Aging$1,270,502
P30 · FY2025 · AG · contact PI
Biological Analysis Core$740,790
U54 · FY2025 · AG · contact PI
Core C - Drug Discovery and Development Core (DDDC)$492,809
P01 · FY2025 · AG · contact PI
Development of novel therapeutics targeting the identified pathways associated with human longevity$440,124
U19 · FY2025 · AG · contact PI
Administrative/Program Enrichment Core$254,102
P30 · FY2025 · AG · contact PI
Core B: Research and Development$254,100
P30 · FY2025 · AG · contact PI
Administrative Supplement to U54 AG079754: Midwest Murine-Tissue Mapping Center (MM-TMC)$200,000
U54 · FY2025 · AG · contact PI
Midwest Murine-Tissue Mapping Center (MM-TMC)$2,700,000
U54 · FY2024 · AG · contact PI
Genetic variant-based drug discovery targeting conserved pathways of aging$2,694,643
U19 · FY2024 · AG
Biological Analysis Core$705,643
U54 · FY2024 · AG · contact PI
Core C - Drug Discovery and Development Core (DDDC)$547,454
P01 · FY2024 · AG · contact PI
Genetic variant-based drug discovery targeting conserved pathways of aging$2,822,483
U19 · FY2023 · AG
Biological Analysis Core$766,535
U54 · FY2023 · AG · contact PI
Drug Discovery and Development$534,392
P01 · FY2023 · AG · contact PI
Biological Analysis Core$760,646
U54 · FY2022 · AG · contact PI
Drug Discovery and Development$521,461
P01 · FY2022 · AG · contact PI
Biological Analysis Core$827,998
U54 · FY2021 · AG · contact PI
Drug Discovery and Development$616,053
P01 · FY2021 · AG · contact PI
Screening and testing of compounds that target the identified pathways associated with human longevity$474,656
U19 · FY2020 · AG · contact PI
Drug Discovery and Development$448,757
P01 · FY2020 · AG · contact PI
2020 Extracellular Vesicles Gordon Research Conference and Seminar$27,660
R13 · FY2020 · TR · contact PI
Drug Discovery and Development$563,892
P01 · FY2019 · AG · contact PI
Screening and testing of compounds that target the identified pathways associated with human longevity$457,681
U19 · FY2019 · AG · contact PI
Administrative Supplement to: Cell Autonomous and Non-Autonomous Mechanisms of Aging$308,419
P01 · FY2019 · AG · contact PI
Screening and testing of compounds that target the identified pathways associated with human longevity$457,674
U19 · FY2018 · AG · contact PI
Extracellular vesicles as cell non-autonomous geronic factors$385,000
R56 · FY2018 · AG · contact PI
Screening and testing of compounds that target the identified pathways associated with human longevity$195,426
U19 · FY2018 · AG · contact PI
2018 Extracellular Vesicles: From basic research to clinical diagnostic and therapeutic applications GRS/GRC$23,400
R13 · FY2018 · TR · contact PI
Cell Autonomous and Non-Autonomous Mechanisms of Aging$1,976,087
P01 · FY2017 · AG · contact PI
Screening and testing of compounds that target the identified pathways associated with human longevity$489,923
U19 · FY2017 · AG · contact PI
CELL AUTONOMOUS AND NON-AUTONOMOUS MECHANISMS BY WHICH NF-KB PROMOTES AGING$329,926
P01 · FY2017 · AG · contact PI
METABOLISM AND AGING$195,664
P01 · FY2017 · AG · contact PI
Cell Autonomous and Non-Autonomous Mechanisms of Aging$140,734
P01 · FY2017 · AG · contact PI
Cell Autonomous and Non-Autonomous Mechanisms of Aging$2,116,821
P01 · FY2016 · AG · contact PI
CELL AUTONOMOUS AND NON-AUTONOMOUS MECHANISMS BY WHICH NF-KB PROMOTES AGING$329,927
P01 · FY2016 · AG · contact PI
METABOLISM AND AGING$195,663
P01 · FY2016 · AG · contact PI
Cell Autonomous and Non-Autonomous Mechanisms of Aging$2,053,317
P01 · FY2015 · AG · contact PI
CELL AUTONOMOUS AND NON-AUTONOMOUS MECHANISMS BY WHICH NF-KB PROMOTES AGING$320,028
P01 · FY2015 · AG · contact PI
METABOLISM AND AGING$189,792
P01 · FY2015 · AG · contact PI
Cell Autonomous and Non-Autonomous Mechanisms of Aging$99,833
P01 · FY2015 · AG · contact PI
Cell Autonomous and Non-Autonomous Mechanisms of Aging$2,098,576
P01 · FY2014 · AG · contact PI
CELL AUTONOMOUS AND NON-AUTONOMOUS MECHANISMS BY WHICH NF-KB PROMOTES AGING$324,772
P01 · FY2014 · AG · contact PI
METABOLISM AND AGING$193,399
P01 · FY2014 · AG · contact PI
Cell Autonomous and Non-Autonomous Mechanisms of Aging$150,000
P01 · FY2014 · AG · contact PI
Cell Autonomous and Non-Autonomous Mechanisms of Aging$2,224,273
P01 · FY2013 · AG · contact PI
CELL AUTONOMOUS AND NON-AUTONOMOUS MECHANISMS BY WHICH NF-KB PROMOTES AGING$324,772
P01 · FY2013 · AG · contact PI
METABOLISM AND AGING$215,154
P01 · FY2013 · AG · contact PI
LMP and Bone Healing$404,007
R01 · FY2012 · AR · contact PI
LMP and Bone Healing$311,673
R01 · FY2011 · AR · contact PI
LMP and Bone Healing$324,814
R01 · FY2010 · AR · contact PI
ROLE OF NF-kB IN STEM CELLS AGING$83,241
P30 · FY2010 · AG · contact PI
LMP and Bone Healing$328,247
R01 · FY2009 · AR · contact PI
ROLE OF NF-kB IN STEM CELLS AGING$89,121
P30 · FY2009 · AG · contact PI
LMP and Bone Healing$328,394
R01 · FY2008 · AR · contact PI
VECTOR CORE FACILITY$146,505
P30 · FY2008 · CA · contact PI
2008 Viral Vectors for Gene Therapy, The Science of Gordon Research Conference$15,000
R13 · FY2008 · HL · contact PI
VECTOR CORE FACILITY$157,890
P30 · FY2007 · CA · contact PI
VECTOR CORE FACILITY$60,254
P30 · FY2006 · CA · contact PI
Inhibition of NF-KB to Facilitate Islet Transplantation$145,761
R21 · FY2003 · AI
Molecular and cellular oncology program$250,404
P30 · FY2002 · CA
Core--Vector$250,404
P30 · FY2002 · CA
REGULATION OF TRANSCRIPTION BY THE RB ANTIONCOGENE$241,754
R01 · FY2002 · CA
Inhibition of NF-KB to Facilitate Islet Transplantation$146,276
R21 · FY2002 · AI
CORE--VIRUS VECTOR$103,677
P01 · FY2002 · DK
Molecular and cellular oncology program$250,404
P30 · FY2001 · CA
Core--Vector$250,404
P30 · FY2001 · CA
REGULATION OF TRANSCRIPTION BY THE RB ANTIONCOGENE$234,715
R01 · FY2001 · CA
CORE--VIRUS VECTOR$103,677
P01 · FY2001 · DK
Core--Vector$0
P30 · FY2001 · CA
Molecular and cellular oncology program$0
P30 · FY2001 · CA
GENERATION OF ANIMAL MODELS FOR ARTHRITIS$503,185
N01 · FY2000 · AR
REGULATION OF TRANSCRIPTION BY THE RB ANTIONCOGENE$227,878
R01 · FY2000 · CA
CORE--VIRUS VECTOR$155,376
P01 · FY2000 · DK
Core--Vector$0
P30 · FY2000 · CA
Molecular and cellular oncology program$0
P30 · FY2000 · CA